Daijiworld Media Network - Abu Dhabi (SP)
Abu Dhabi, Jun 16: As per an agreement reached between Abu Dhabi health department and GlaxoSmithKline, the city became the first in the world to receive antiviral treatment drug for Covid-19, Sotrovimab. The first ever consignment of this revolutionary drug was received by the city on Wednesday June 15.
Sotrovimab is a monoclonal antibody treatment delivered through intravenous therapy for adults and children above 12 years of age who are at risk for progressing to severe Covid-19. Clinical trials have shown that the drug prevents hospitalisation and death in 85 percent of cases and the drug works on all variants of the virus till now.
The UAE health ministry gave its approval for the drug after USA Food and Drug Administration allowed emergency use of this medicine. Under secretary in the department of health, UAE, Dr Jama Mohammed Kaabi, said that Abu Dhabi continues with its efforts to maintain its number one city position globally in terms of safety in Covid-19 times. Rashd Al Qubaisi, CEO of Abu-Dhabi based Rafed, which facilitates the procurement of the medicine, said that Sotrovimab is a huge breakthrough in the fight against Covid-19.The health department is working out the eligibility for Sotrovimab treatment.